Press Releases
- TGA approves Zejula for ovarian cancer providing another option for newly diagnosed women with this deadly disease
- Global innovation in intensive care research wins Australian duo GSK Award for Research Excellence
- GSK Australia Celebrate Launch of Reconciliation Action Plan
- Experts map “post-jab” future in GSK-sponsored panel discussion
Tweets from GSK AU
-
GSK_AU @GSK_AU
We're kicking off #2022 by recognising some of the highlights from the last 12 months. We're proud to continue to support Australian medical researchers in driving important learning and advancements in healthcare through our longstanding grant initiatives. #GSKcelebrates
about 3 days ago
-
GSK_AU @GSK_AU
We are pleased to announce that @TGAgovau has approved our #PARPi for the treatment of women with newly diagnosed advanced #OvarianCancer following response to platinum-based chemotherapy—providing another option for women facing this challenging disease. au.gsk.com/en-au/media/pr…
about 10 days ago
-
GSK_AU @GSK_AU
Up to 80% of people with asthma also have allergies. Allergens can cause inflammation in the airways, worsening asthma & the occurrence of asthma attacks. #ActOnAsthma today. Talk to your doctor about getting your asthma controlled to help reduce your risk during allergy season.
about 30 days ago
